본문

  1. Home
1000 Results:AA:B PP:ELSEVIER INC 0.364 sec.
RSS 
Multilingual
 高度な検索
 新しい到着検索
選択した印刷 Select Export to Excel
231
The effect of a fortified milk drink on vitamin D status and bone turnover in post-menopausal women from South East Asia
The effect of a fortified milk drink on vitamin D status and bone turnover in post-menopausal women from South East Asia
Kruger, M. C., | Elsevier Inc | 2010 ,
232
RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis
RANKL-targeted therapy inhibits bone resorption in experimental Staphylococcus aureus-induced arthritis
Verdrengh, M., | Elsevier Inc | 2010 ,
233
Comparison of hip fracture risk prediction by femoral aBMD to experimentally measured factor of risk
Comparison of hip fracture risk prediction by femoral aBMD to experimentally measured factor of risk
Roberts, B. J., | Elsevier Inc | 2010 ,
234
Zinc deficiency suppresses matrix mineralization and retards osteogenesis transiently with catch-up possibly through Runx 2 modulation
Zinc deficiency suppresses matrix mineralization and retards osteogenesis transiently with catch-up possibly through Runx 2 modulation
Kwun, I. S., | Elsevier Inc | 2010 ,
235
Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expression
Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expression
Kwak, H. B., | Elsevier Inc | 2010 ,
236
Ubiquitous overexpression of Hey1 transcription factor leads to osteopenia and chondrocyte hypertrophy in bone
Ubiquitous overexpression of Hey1 transcription factor leads to osteopenia and chondrocyte hypertrophy in bone
Salie, R., | Elsevier Inc | 2010 ,
237
Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity
Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity
Gourion-Arsiquaud, S., | Elsevier Inc | 2010 ,
238
Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: The DIVA study
Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: The DIVA study
Recker, R. R., | Elsevier Inc | 2010 ,
239
The effect of risedronate on hip structural geometry in chemotherapy-induced postmenopausal women with or without use of aromatase inhibitors: A 2-year trial
The effect of risedronate on hip structural geometry in chemotherapy-induced postmenopausal women with or without use of aromatase inhibitors: A 2-year trial
van Londen, G. J., | Elsevier Inc | 2010 ,
240
No anti-angiogenic effect of clinical dosing regimens of a single zoledronic acid injection in an experimental bone healing site
No anti-angiogenic effect of clinical dosing regimens of a single zoledronic acid injection in an experimental bone healing site
Biver, E., | Elsevier Inc | 2010 ,
처음이전19202122232425262728이후마지막